Europska Unija - hrvatski - EMA (European Medicines Agency)

bayer ag - darolutamide - tumori prostate, Кастраци-uporan - endokrinska terapija - nubeqa is indicated for the treatment of adult men with- non metastatic castration resistant prostate cancer (nmcrpc) who are at high risk of developing metastatic disease (see section 5. - metastatic hormone sensitive prostate cancer (mhspc) in combination with docetaxel and androgen deprivation therapy (see section 5.

Europska Unija - hrvatski - EMA (European Medicines Agency)

novartis europharm limited  - alpelisib - neoplazme dojki - antineoplastična sredstva - piqray je navedeno u kombinaciji s fulvestrant za liječenje žena nakon menopauze, a muškaraca hormon receptor (op)-pozitivan, людское эпидермическое ako uređaj primatelja 2 faktor rasta (her2 i)-negativan, lokalno-uobičajena ili metastatskih tumora dojke s mutacija pik3ca nakon progresije bolesti nakon hormonske terapije kao monoterapija (vidi odjeljak 5.

Europska Unija - hrvatski - EMA (European Medicines Agency)

accord healthcare s.l.u. - abirateron acetat - prostatske neoplazme - endokrinska terapija - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Europska Unija - hrvatski - EMA (European Medicines Agency)

gedeon richter plc. - relugolix, norethisterone acetate, estradiol hemihydrate - uterusa - hipofiza i hipotalamusni hormoni i analozi - ryeqo is indicated in adult women of reproductive age for:- treatment of moderate to severe symptoms of uterine fibroids,- symptomatic treatment of endometriosis in women with a history of previous medical or surgical treatment for their endometriosis.

Europska Unija - hrvatski - EMA (European Medicines Agency)

gedeon richter plc. - drospirenone, estetrol monohydrate - contraceptives, oral - spolni hormoni i modulatori genitalnog sustava, - oral contraceptive.

Europska Unija - hrvatski - EMA (European Medicines Agency)

estetra sprl - estetrol monohydrate, drospirenone - contraceptives, oral - spolni hormoni i modulatori genitalnog sustava, - oralna kontracepcija. the decision to prescribe lydisilka should take into consideration the individual woman’s current risk factors, particularly those for venous thromboembolism (vte), and how the risk of vte with lydisilka compares with other combined hormonal contraceptives (chcs) (see sections 4. 3 and 4.

Europska Unija - hrvatski - EMA (European Medicines Agency)

krka, d.d., novo mesto - abirateron acetat - prostatske neoplazme - endokrinska terapija - abiraterone krka is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt) (see section 5. 1)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. 1)the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.

Europska Unija - hrvatski - EMA (European Medicines Agency)

accord healthcare s.l.u. - relugolix - prostatske neoplazme - endokrinska terapija - orgovyx is indicated for the treatment of adult patients with advanced hormone-sensitive prostate cancer.

Europska Unija - hrvatski - EMA (European Medicines Agency)

accord healthcare s.l.u. - leuprorelin mesilate - prostatske neoplazme - endokrinska terapija - camcevi is indicated for the treatment of hormone dependent advanced prostate cancer and for the treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy.

Europska Unija - hrvatski - EMA (European Medicines Agency)

theramex ireland limited - linzagolix choline - uterusa - hipofiza i hipotalamusni hormoni i analozi - yselty is indicated for the treatment of moderate to severe symptoms of uterine fibroids in adult women of reproductive age.